Form 8-K - Current report:
SEC Accession No. 0001104659-19-073600
Filing Date
2019-12-18
Accepted
2019-12-18 09:00:16
Documents
4
Period of Report
2019-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1926480d1_8k.htm 8-K 27019
2 EXHIBIT 1.1 tm1926480d1_ex1-1.htm EX-1.1 228416
3 EXHIBIT 99.1 tm1926480d1_ex99-1.htm EX-99.1 11031
4 GRAPHIC image_001.jpg GRAPHIC 4636
  Complete submission text file 0001104659-19-073600.txt   274365
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 191291418
SIC: 2834 Pharmaceutical Preparations